24653
document
[ Clinical study of feiyanqing rectum condensed liquid in treating 36 cases of children syncytial viral pneumonia ] . OBJECTIVE To evaluate the clinical efficacy and mechanism of Feiyangqin Rectum Condensed Liquid ( FRCL ) in treating children syncytial viral pneumonia . Methods Seventy-two patients were randomly divided into two groups , the 36 patients in the treated group were treated with FRCL , and the other 36 patients in the control group simply treated with Western medicine . Efficacy of treatment on clinical condition and some immune function ( IgA , IgG , CD3 , CD4 ) were observed . RESULTS In the treated group , 28 patients were cured ( 77.8 % ) , treatment was markedly effective in 4 patients ( 11.1 % ) , effective in 2 ( 5.5 % ) and ineffective in 2 ( 5.6 % ) , with the total effective rate of 94.4 % . The corresponding number in the control group was 20 ( 55.6 % ) , 7 ( 19.4 % ) , 6 ( 16.7 % ) , 3 ( 8.3 % ) and 91.7 % , respectively . The cure rate in the treated group was obviously superior to that in the control group ( P < 0.05 ) . FRCL could improve serum IgA , IgG , CD3 , CD4 , and CD4/CD8 , lower serum IgE , these indexes in the treated group were significantly different to those in the control group ( P < 0.05 ) . CONCLUSION FRCL had the action in treating children syncytial viral pneumonia without any adverse reaction , one of its mechanisms might be related to its regulation on immune function .
24654
Intervention_Pharmacological
feiyanqing rectum condensed liquid
24655
Intervention_Pharmacological
Feiyangqin Rectum Condensed Liquid ( FRCL )
24656
Intervention_Pharmacological
FRCL
24657
Intervention_Control
Western medicine .
24658
Intervention_Pharmacological
FRCL
24659
Intervention_Pharmacological
FRCL
24660
Outcome_Other
Efficacy
24661
Outcome_Physical
immune function ( IgA , IgG , CD3 , CD4 )
24662
Outcome_Other
cured
24663
Outcome_Other
total effective rate
24664
Outcome_Other
cure rate
24665
Outcome_Other
serum IgA , IgG , CD3 , CD4 , and CD4/CD8 , lower serum IgE
24666
Participant_Age
children
24667
Participant_Condition
syncytial viral pneumonia
24668
Participant_Sample-size
Seventy-two
24669
Participant_Sample-size
36 patients
24670
Participant_Sample-size
36 patients